Genmab A/S (GMAB) Q4 2021 Earnings Conference Call February 16, 2022 12:00 PM ET Company Participants Jan van de Winkel – President and Chief Executive Officer Anthony Pagano – Chief Financial Officer Anthony Mancini – Chief Operation Officer Tahi Ahmadi – Chief Medical Officer Conference Call Participants Wimal Kapadia – Bernstein James Gordon – JP Morgan Kennen MacKay – RBC Paul – Guggenheim Securities Elizabeth Walton – Credit Suisse Peter Virgil – Citi Asthika Goonewardene – Truist Securities Peter Welf ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ◻ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 1 ...

GENMAB 2021 ANNUAL REPORT Table of Contents Using Science to Turn Insights into Medicine | MANAGEMENT'S REVIEW | | | --- | --- | | About Genmab | 3 | | Who We Are | 3 | | Timeline | 5 | | 2021 at a Glance | 6 | | Our World-class Team | 7 | | Commercialization | 8 | | Chair's Statement | 9 | | Letter from the CEO | 11 | | Consolidated Key Figures | 13 | | 2022 Outlook | 15 | | Business Model | 16 | | Our Strategy | 18 | | Our Business | 20 | | Research and Development Capabilities | 20 | | Antibody Discovery ...

Genmab A/S (GMAB) Q3 2021 Results Conference Call November 10, 2021 12:00 PM ET Company Participants Jan van de Winkel - President and CEO Anthony Pagano - CFO Judith Klimovsky - Chief Development Officer Anthony Mancini - COO Conference Call Participants Wimal Kapadia - Bernstein James Gordon - JP Morgan Kennen MacKay - RBC Jonathan Chang - SVB Leerink Michael Schmidt - Guggenheim Securities Sachin Jain - Bank of America Matt Weston - Credit Suisse Peter Welford - Jefferies Asthika Goonewardene - Truist Se ...

Quarter End Results Period Ended September 30, 2021 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including develop ...

Genmab A/S (GMAB) Q2 2021 Results Conference Call August 11, 2021 12:00 PM ET Â Company Participants Jan van de Winkel - President and CEO Anthony Pagano - CFO Judith Klimovsky - Chief Development Officer Anthony Mancini - COO Tahi Ahmadi - Chief Medical Officer Conference Call Participants Wimal Kapadia - Bernstein Elizabeth Walton - Credit Suisse Emily Field - Barclays James Gordon - JP Morgan Michael Novod - Nordea Michael Schmidt - Guggenheim Securities Graig Suvannavejh - Goldman Sachs Jonathan Chang - ...

Quarter End Results Period Ended June 30, 2021 Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial position, business strategy, plans and objectives of management for future operations (including development ...

Genmab A/S (GMAB) Q1 2021 Earnings Conference Call May 5, 2021 12:00 PM ET Company Participants Jan van de Winkel - Co-Founder, President & Chief Executive Officer Anthony Pagano - Chief Financial Officer | --- | |------------------------------------------------------| | | | Conference Call Participants | | Wimal Kapadia - Bernstein | | Michael Schmidt - Guggenheim | | Jonathan Chang - SVB | | Emily Field - Barclays Sachin Jain - Bank of America | | Trung Huynh - Crédit Suisse | | Peter Welford - Jefferies ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ◻ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ⌧ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ◻ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 1 ...

· Genmab Year End Results Period Ended December 31, 2020 © Genmab For Investor audience only. Not for public information or use. Not for promotional use. Forward looking statement This presentation contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. All statements other than statements of historical facts included in this presentation, including, without limitation, those regarding our financial po ...